VivaShit Flashcards

1
Q

Caudal boundary of external iliac nodes

A

Contour around with a 7mm brush(like everywhere except obturators):
Transition from the inguinal area, when the vessels adopt a horizontal path above the upper edge of the iliopubic ramus.
** Should be at the very apical border of the femoral heads.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Boundaries for obturator nodes

A

Use 18mm brush:
Caudal edge is the apical pubic symphysis
Ant and post edges of iliac bone on axial (imagine a coronal line) define the ant and post borders.
Continue up til you hit the horizontal path of the externals.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Some technical downsides of VMAT:

A

VMAT: Gantry and MLCs both moving during dose delivery:

Potential for high MU
higher MLC leak/penumbra.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Anatomical boundaries of:
IMN (just the sup inf)
SCF

A

1) Sup aspect 1st rib, superior aspect of 4th rib.

2) Sup edge: Caudal to cricoid,
Inf edge: Caudal edge of clavicula head.
Ant: SCM
Post: Ant surface of scalenes
Medial: exclude thyroid and trachea
Lateral: in neck then lateral edge of SCM, lower junction of 1st rib and clavicle.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Relationship between heart dose and cardiotoxicity risk:

Basic interventions to minimise RISK:

A

7%/Gy linear w/no apparent threshold.

1) No Herceptin or acanthrocylines during/around treatment

2) Treatment techniques:
a) Position
- DIBH - typical MHD (left sided) around 1.5Gy vs 2.5Gy free breathing.
- Prone position.
- Lateral decubitis position.
b) Technique:
- conformal IMRT/VMAT
- Wide tangent in conjunction w/DIBH has been shown to reduce dose further.
- Electrons for IMN.

3) Minimise modifiable cardiac risk factors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Benefit of hormone therapy in Br Ca:

Also give doses because the College are cunts who’ve conflated memory with intelligence.

A

EBCTG:
Tamoxifen:
Overall BCS improved by 10% at 10yrs.
LN -ve = 5%
LN +ve = 12%

ATAC - AI superior to tamox in post meno

SOFT-Tex:
Ovarian Suppression + AI
OS benefit even in LN-ve - but high drop out rate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Define brachytherapy

Essential components of a HDR brachytherapy system:

A

Sealed source placed in (interstitial) or in contact (intravity/mould/plaque) with the tumor providing high dose to the tumor with small volumes of normal tissue irradiated.

Operating console of the remote afterloader unit,
remote afterloader unit,
radioactive source,
transfer tubes,
afterloading catheters and applicators,
treatment planning system.
Safety system - Bunker, afterlocks, emergency procedures.

QA tests for:
Mechanical, planning, radiation, safety, electrical systems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

In terms of brachytherapy define LDR and HDR:

A

Low dose rate (LDR)
(0.4 - 2 Gy/h)

HDR
(>12 Gy/h)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The essential components of remote afterloading
machines:

A
  • A safe to house the radioactive source
  • Radioactive sources (single or multiple)
  • Remote operating console
  • Source control and drive mechanism
  • Source transfer guide tubes and treatment applicators
  • Treatment planning computer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

For each of these systemic therapies give the side effects for which they are famous:
Taxanes
Cisplatin
Carboplatin
5-FU
Capecitabine
Etoposide
Ritux
Cetuxumab

A

Taxanes: Perif neuropathy - cardiomyopathy if used with Acanthracycline.

Cisplatin: Neuropthy, ottotoxicity, nephropathy, N&V

Carboplatin: Myleosuppression

5-FU: Mucocitis, hand foot and mouth - like rash, coronary artery spasm
Capecitabine: Is converted to 5-FU

Etoposide: Myleosuppression

Ritux: Super COVID

Cetuxumab: Skin rash - 95% of the time.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe a 3D breast plan:

How would you improve homogeneity (while not changing technique)?

A

Whole Breast/Chest wall only:
Opposing pair tangential fields, with non-divergent posterior edge.

Breast/ CW + SCF + IMC:
Mono-isocentric technique
- Breast/CW: 2 As above.
- IMN: wide tangent field crossing midline to cover IMN (or electrons)
- SCF: AP field, junction inferior edge with tangent field, angled 10deg off cord, 6MV energy
prescribed to 3cm depth

  • Options to improve homogeneity
    o Bilateral wedge (with thick edge anteriorly)
    o Field in field/ subfields
    o Hybrid IMRT
    o Electronic compensation (ECOMP)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe a whole brain technique for multiple brain mets:

A

Whole brain RT 30Gy/10#s, 3Gy/# VMAT technique with hippocampal sparing. 6MV photons. Prescribed to D50. Would include down to C2 if post fossa mets.

Pre sim: dex, analgesia, anti seizure as required.

Sim: Supine, head towards gantry, knee and ankle supports. Immob with thermoplastic mask.
1mm Slice CT scalp vertex to C7. Planing MRI (T1) to help deliniate hippos.

Volumes:
CTV = whole brain.
Hippocampal Avoidance Zone = bilateral hippos +5mm.
PTV = CTV+5mm with the hippocampal avoidance zone subtracted from this volume.

Goals:
1) Hippo:
Aim max dose <16Gy
Min dose <9Gy.
Blah.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Mechanical vs Radiation isocentre (2019)
- Define
- How is it checked
- How often checked in QA

If the isocentre was off by 2-3mm, what would the problem be?

A

Mechanical isocentre. Point in space around which couch and gantry rotate. affected by sagging of collimator head by gravity.

Radiation isocentre: A point like volume where the beams intersect when couch, gantry or colimator is rotated. Daily QA - Radiation isocentre kept within 1mm movement within all planes. Rough guideis bunker lasers and a laser son the gantry.

Isocentre off by 2-3mm effects dosimetry and accuracy, with this effect amplified in non-coplaner plans (e.g. SABR).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Where do you place the isocentre
Eg in setting of re-irradiation or at nearby site
And other scenarios?

A

1) Single field either surface or at depth (no signif diff)
2) Asymmetric fields (one or both of X and Y collimator settings are not equal) have 2 benefits. 1st enable a tx plan isocentre to be located on a convenient anatomical set-up point rather than being restricted to the centre of the PTV. 2nd, enables the beam divergence of adjacent fields to be matched to one another.

E.g. posterior part of simple breast tangent pair has non divergent edge aligned posteriorly.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

In incredibly simple terms - Larger linac field sizes do what

A
  • Increased secondary electrons - higher surface dose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is a monitor unit

A

The amount of charge measured in an ionisation chamber in the linac head which correlates to a dose of 1cGy measured in a water phantom on the central axis in fixed conditions. Allows direct monitoring of linac output in a dose related way (but does not reflect field size changes ect).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Benefit of using Flattening Filter Free approach:

Disadvantages

A

Bene: Tight control of fluence, higher dose rate (less treatment time), much less scatter from treatment head. Reduced out of field dose. Good for patient motion - preferred for SABR.

Dis: Very high dose rate can quickly deliver unintended high dose to OAR if unplanned patient movement. Not suited to larger field size SABR.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What should TSH be prior to RAI?

Advice to achieve this:

Alternative method:

Diet advice

A

> 30 mIU/L

Cease thyroxine 4 weeks prior. Restart day 3 post.

Recombinant human TSH (Thyrogen) - 2 injections 24 hours apart, just prior to RAI to raise TSH level rapidly

Low iodine diet to commence 2 weeks prior.
NBM for 2 hours prior to administration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Definite indications to NOT give RAI for thyroid cancer:

Contraindications

A

Small tumors less than 1-2 cm confined to the thyroid gland with no evidence of spread to the lymph nodes or surrounding tissues.

Contraindications:
1) Pregnancy or desire too become preg in the next 6-12 months. Discuss role of contraceptives.
2) Unable to comply with safety guidelines.
3) Graves eyedisease
4) Currently unwell with GI upset.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Advice post RAI

A

1) Will have uptake scan 1 week post

Precautions:
Avoid close contact with children <5 and preg ladies for 3 weeks.
Avoid preg (or trying to make a baby if a dude) for 6-12 months.

For 7 days:
- Avoid sleeping in the same bedroom as another person
- Use your own set of crockery and cutlery and wash separately. Alternatively use disposable cutlery
- Refrain from food preparation and dishwashing
- Double wash clothes. Wash separately from clothes of others
- Continue to double flush the toilet

For 3 days:
Keep pets at arms length

Avoid visiting places of entertainment or going to work

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Verbalize (in order) the list of shit you would say for a compromised PTV/CTV plan:

A

“I would review the plan in detail ensuring that:
- The volumes are correct
- Noting the location of hotter spots, cold spots, considering beam energies.
- OAR dose and the extent of compromise.

IMRT/VMAT:
“I would re-plan with a change of weights on more critical OARS”

3D:
“consider beam arrangements, Add beams, consider wedges, bolus, more conformal technique”

If still no love:
Consider the likie consequences of increased dose to OARS vs PTV compromise and discuss with patient with informed consent.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Steps of describing sim/pre-sim:

A

Pre sim:
Beta HcG if appropriate
Dental - H&N
Dex/anti seizure
Analgesia/PRNS
Specific consent - e.g. retreat H&N

Sim (they want added detail):
Position: including arm/shoulder
Organ requirements: e.g “comfortably full bladder”
Bolus
Markers - e.g prostate fiducials.
Other - I always forget this - e.g. tampon for cervix plan.
CT
almost always say would fuse relevant diagnostic imaging.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Describe Sim for a head and Neck treatment:

A

Pre-sim:
Dental review and necessary treatment complete
Consider dietician
PEG
Smoking cessation
Analgesia and adequate supply PRNs

Sim:
Supine head towards gantry in neutral position, shoulders low, arms by side.
Immobilisation w/thermoplastic mask, knee and ankle supports.
1mm slice contrast ct, scalp vertex to upper thorax, fused with MRI T1+C and relevant diagnostic imaging including PET.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Pathophys of acute oesophagitis:

Risk factors:

A

Acute inflammation of the esophageal mucosa - especially the basal layer where treatment induced cell death leads to reduced production and subsequent depletion. This leads to mucosal abrasion and ulceration

Patient: age>70, co-morbidities esp existing dysphagia, previous esophageal surgery.
Tumour: T and Nstage
Treatment: Dose, fractionation, volume, CONCURRENT CHEMO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Pathophys of late oesophagitis:

A

Cellular injury leads to release of ROS and increased migration of inflammatory cells, sustained relese of inflammatory markers (e.g Il-1, Il-2, TGF) and fibroblast migration/maturation and increased ECM matrix pproduction of clollagen leading to fibraosis - altering muscle function, and causing stenosis. May clinically manifest as stricture, fistula, chronic ulceration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Mx of acute RT oesophagitis:

A

1) Prevention
2) Topical anaethetic - pre meals.
3) Reduce reflux
4) Appropriate analgesia
5) Dietician review and soft diet and trigger foods (e.g. chili)
6) Prophylactic RIG in some cases.

26
Q

Mx of late RT oesophagitis:

A

1) referral to a speech path and or dietician -strategies to maintain appropriate nutritional intake.
2) Gastroenterologist opinion RE dilatation

27
Q

Malignant bowel obstruction Mx:

A

Principle is if non-operative care adapted to severity and goals of care, patient wishes.

1) Initial Mx: Bowel rest, IV fluids, analgesia, gen surg consult if appropriate. Analgesia. Medical Mx may include prokinietics,, anti-secetory, NGT, as appropriate.
2) Progression/worsening Sx: Medical Mx = steroids, prokinetics, anti secretory, temporary NGT. Palliative care review.
3) Intractable: Best supportive care practices for comfort dignity, family support.

28
Q

Moderate hypercalcaemia is greater than?

Severe is greater than?

Name the 3 main pathways

A

> 3mmol/L

> 3.4mmol/L

1) Osteolytic mets
2)Tumour secreting PTHrP
3) Tumour production of Calcitrol (blocks osteoclasts)

29
Q

Just list the agents that may be used for hyperCa (there are 5):

A

1) IV fluids - 1st line
2) Bisphos IV over 15mins - watch renal function, and Ca
3) Denosumab - not in the acute setting watch for hypoCa
4) Calcitonin reserve for very severe >3.5, only transient and tolerance develops quickly.
5) Glucocorticoids - only where HyperCa due to lymphoma and multiple myeloma. can take a week to kick in.

30
Q

When does a pacemaker need function assessment?

What precautions during radiation delivery?

A

All need pretreatment. And at end of treatment.

All dependent need weekly assessment.

Non dependent need weekly if:
>10MV (or 20MeV) though avoid if possible.
Cumulative dose >=5Gy

During Beam on:
All Dependent = vital signs
All altered function (e.g. turn off) = vital signs.
All>5Gy cumulative = vital signs
All>10MV = vital signs.

31
Q

Risk factors for vaginal dryness:

A

Oophrectomy
Dose to ovaries >7Gy
menopause/age>50
Andrew Tate

32
Q

Risk factors for vaginal stenosis

A

Patient:
Age>50
Smoking
Co-morbidities. - T2DM, PVD

Treatment:
Dose, hypofractionation, volume.

33
Q

48F Left 28mm, poorly differentiated SCC of anterior tongue, x2 LEFT level 2 nodes. Lingual nerve invasion.

Hemi-glossectomy:
1mm margin, left neck dissection nodes fully excised.

What do you do?

A

(Note about +ve margins. NCCN: <1mm is positive, <5mm = close).

Given lesion PD and node +ve I would consider 1mm +ve. Can consider concurrent Chemo.

Therefore I would treat EBRT, VMAT SIB technique to a maximum dose of 63/30, 5#s/week. Prescribed to D50.

Pre sim:
Dental review and necessary work
Consider PEG
Analgesia/PRN/anxiolytics as needed.
Dietician
Smoking cessation
and other allied health such as psychology as needed.

Sim:
Supine, head towards gantry, in neural position, arms by side shoulders lowered. Immobilisation with thermoplastic mask, knee and ankle supports.
2mm slice CT+contrast, vertex to upper thorax. Fused w/planning MRI and pre-operative imaging.

Volumes:
CTV63= Tumour bed based on imaging expanded by 5mm and trimed to boundaries.
CTV60=CTV63+1cm trimmed to boundaries.
CTV56=dissected nodal levels AND lingual nerve to the stylomastoid foramen - could consider path of V3 to foramen.
CTV54 = CTV56 + undisected bilateral nodes: 1a, 1B, II, III and IV. I would treat level V on ipsilateral side and omit IIa on the contraleral side.
PTV = CTV54+7mm

Daily CBCT matched to bone with soft tissue review.
OARS (in EQD2): Brain Dmax<60Gy, lens Dmax<6Gy, retina mean <45Gy, Lacrimal duct Dmean<30Gy, Parotid mean<26Gy, mandible avoid hotspots, cervical eso mean<30Gy,

34
Q

What concurrent chemo radiation patients w.diarhoea are at particularly high risk of morbidity/mortality?

What treatment related diarrhoea should you approach differently?

Average dose/time of onset?

Pathophys of RT induced hyperpoops?

A

Neutropenic patients very high risk.

Immunotherapy (PD-1, PD-L1, CTLA4) - do not give lopermide, requires teatment per protocol.

at 10Gy to 30Gy, typically week 3 of conventional RT.

Multifactorial: Epithelial crypt cell death leading to inflammation, ulceration, leading to increased damage from bile salts and risk of infection and malabsorption

35
Q

Approach to RT diarrhoea:

A

1) Minimise risk: OARS, fractionation, positioning, bladder filling, patient education
2) Non-pharm: Hydration, patient monitoring their own output, lactobacillus pro-biotic
3)Pharmacological:
- Initial loperimide (i.e. 1st 4mg, then 3mg after every watery poo).
- If not controlling consider treatment options (e.g. cease chemo, review CBCTs ect)
- Some second-line - octreotide, ondasetron.

36
Q

Because the College is an autistic echo chamber, where regurgitating lists is mistaken for actual knowledge (or knowledge synthesis):

1) Give all the terms you might use to describe the shape of a lesion.
2) Word for red/purple.
3) Differentials for a skin lesion

A

1) Macule/Patch, plaque, papule, nodule.
2) Violatious.

3) DDx:
SCC,
keratokanthoma,
Bowens disease,
Solar keratosis,
BCC,
ulcerating BCC,
Merkel cell,
Melanoma - Lentigo maligna, superficial spreading, nodular, amelanocytic, desmoplastic ect
Cutaneous mets - e.g Breast, H&N mucosal SCC,
Lymphoma (MF or Serazry), DLBCL (e.g. leg type).
Benign: granuloma, dermatofibroma, neurofibroma, cellulitis/lymphangitis/abscess.

37
Q

Because the College is an autistic echo chamber, where regurgitating lists is mistaken for actual knowledge (or knowledge synthesis) Give:

DDx for H&N mucosa lesions

A

SCC, verrucous SCC, leukoplakia, erythroplakia,
Salivary gland tumour- ACC
Adenocarcinoma
Met from distant site
Extra medullary plasma cytoma,
Lymphoma
Sarcoma such as Rhabdo.
Small cell

Other small Small round blue cell tumours of the nasocavity: NUT, olfactory neuroblastoma
Oral cavity - ameloblastoma

38
Q

Prostate fiducials are placed where? Why are they shaped the way they are?

A

Right base, left midzone, Right Apex.

Look Knurled to prevent migration

39
Q

DDx cervix lesion on colposcopy:

A

SCC, endocervical adenocarcinoma, cervical ectropium, scarring (e.g. previous colposcopy), cervix infection, leiymyosarcoma, melanoma.

40
Q

Ion Chambers:
Common use

Advantages:

Limitations:

A

Ion Chambers
accuracy ±1% or less:
-Reference Dosimetry
-Percent Depth Dose Distributions

Adv:
-Best understood
-Sub 1% accuracy possible

Dis
-Low energy dependence
-Size limitations
-Calibration required

41
Q

What do TLDs look like?
- Broad theory of function

Examples of their use (name 3)

Advantages:

Alternative for key dosimetric use

A

Thermo Luminescent device
Crystal structure with impurities - radiation pushes electrons to higher state - impurities trap in these in higher state (though revert slowly overtime).
Heating the crystal causes the electrons to drop back to their ground state, releasing a photon of energy which can be detected and this luminsece if a function of absorbed dose. The function has a linear domain within a window.

Examples:
Invivo dosimetry
Staff monitoring
Environmental monitoring

Adv-
- Do not effect dosimetry
- Easily placed on skin
- Small
- Cheap

Dis:
Decay over time
less accurate - 5%, with variation between batches
Complex processing
non-linear behaviour at higher doses (>2Gy)

MOFSETT are an alternative invio dosimeter that provides instant readout, with no loss over time, and higher accuracy

42
Q

How do you work out thick lead shield for an electron treatment should be?

A

Rule of thumb: divide practical range by 10 to obtain approximate thickness of lead required for shielding (<5% transmission).

Alternative (easier)- 2Mev per mm of lead.

43
Q

2 types of film dosimeters?

Common uses

A

Radiographic - highest spatial resolution (um), but requires chemical processesing to develop/

Radiochromic - No chemical processing, tissue equivalent. Lower spatial accuracy (<1mm)

Disvantage to bose: lower accuracy than
Uses:
-Planar dose distributions
-Electron PDD

44
Q

Alternatives to flab/super flab:

A

Thermoplastic Build up
Paraffin gauze
Perspex
Wax
Wet gauze/combine
3d Printed (resin often polymer with silcone)

45
Q

Skin lesion 1.5cm thick
Choose energy.

Skin lesion 1cm thick
Choose energy.

Zmax for 6Mev
Zmax for 9Mev

A

1) Want 100% at surface and D90 at 1.5cm

Add 1cm bolus to get 100% at surface - now want D90 at 25mm

Rule of 3 for D90:

25mm/3 = 8.something.

So choose 9MeV.

2) 20mm/3 = 6.66
If Available I would choose 7. or a thinner bolus 8mm to use 6MeV
(beam Energies classically 6, 9, 12, 16, and 20 , but some have 7 and 4)

6Mev Zmax - 1.5cm
9Mev - 2cm

46
Q

Most common side effects tamoxifen - which also occur commonly with Aromatase inhibitors?

Additional side effects ore unique to each class:

A

These 3 are common to tamox and AI:
Hotflushes
Vaginal itch/dryness
Loss of libido

Tammox only:
Vaginal discharge

AI:
Myalgia/joint pain
Bone mineral density loss (occurs in post menopausal women on tamox as well

47
Q

Most acutely consequential side effects of tamoxifen and AIs.

Name 3 AIs:
Which is better?

A

Tamox:
DVT/PE
Increased risk of endometrial cancer

AI:
HTN
Cardiovasular disease
Mood changes/depression.

Exemestane, letrozole, anastrazole.
All have equal oncogenic outcomes, select based on cost and toleration.

48
Q

Techniques for breast boost:
When may a particular approach not be suited?

A
  • Electrons: common, however limited use in large breasts, deep tumors, or tumors located in regions with sudden depth change such as inframammary or axillary folds. In these try positioning such as a decubitus position to reduce the maximum distance of the tumor bed to the skin and lower maximal dose to the target volume.
  • Photons: 3 field, mini-tangents, ect.
49
Q

Broadly, where is axillary level III?

How about level II?

A

All about pec minor and major
Its anterior border is the post surface of pec major, it lies medial to pec minor and the cranial border is where it inserts into cricoid. The inferior border is where the vessels cross the edge of pec minor into that medial space (bringing the nodes). Posterior is esy = bounded by the ribs, medially by the inlet.

Level II is easy: its just wrapped around pec minor (i.e ant border ant surface of muscle) and extended posteriorly to the ribs/intercostal muscles. Its cranial edge is in caudal edge of III - where vessels cross lateral edge of pec.min into that medial space.

50
Q

Young woman with red oedematous breasts with multiple nodules (2013)
What are the differentials?

A

Inflammatory breast cancer, mastitis, cellulitis, Pagets, eczema, MELANOMA (this was the answer), Merkels, paraneoplastic dermatomyocitis, sarcoma (e.g. angio), cutaneous lymphoma (MF, Cerazry, DLBCL), mets.

51
Q

Photo of a chest wall – erythema (2012)
Differential diagnosis?
How would you assess?
What would you do if this was only after 18Gy?

In general for Whole Boob, What side effects would you discuss with the patient and what is the incidence of them?

A

History – how long, any symptoms, any treatment, history of malignancies, systemically unwell. Febrile?

Examine: Borders (e.g. conforms to field, extends from nipple), extent, type of erythema (e.g. vesicular) ulcerations, palpable mass, scars.

Too severe for 18Gy. Potential causes: RT dose error, thickness of bolus, radiosensitizing conditions like xeroderma pigmentosa, Li Fraumeni,

If not a technical error - I would consider removing bolus.

Toxicity would include radiation pneumonitis (<2%), rib fracture (<1%), cardiac toxicity (difficult to quantify but rare if minimal exposure), telangiectasia (5-20%), secondary malignancy (<1 in 600)

52
Q

Quickly name a bunch of diseases of the skin (DDX)*:

  • since that is apparently an absolutely critical part of radiation oncology (according to the College).
A

SCC,
keratokanthoma,
Bowens disease,
Solar keratosis,
BCC,
ulcerating BCC,
Merkel cell,
Melanoma - Lentigo maligna, superficial spreading, nodular, amelanocytic, desmoplastic ect
Cutaneous mets - e.g Breast, H&N mucosal SCC,
Lymphoma (MF or Serazry), DLBCL (e.g. leg type).
Benign: granuloma, dermatofibroma, neurofibroma, cellulitis/lymphangitis/abscess.

53
Q

Radiosensitizing conditions that may explain an early skin reaction:

What other patient factor may you consider?

A

Xeroderma pigmentosa, Li Fraumeni, ATM

Inappropriate topical creams (e.g from natropath).

54
Q

Some risk factors for late effects like telangetasia:

A

HTN, Diabetes, collagen vascular disease, ATM.

55
Q

HCC IHC

A

Hep Par1
AFP
Glycogen3.

56
Q

The most common hemorrhagic brain mets:

A

1) Melanoma
2) RCC
3) Cholangiocarcinoma
4) Papillary Thyroid

57
Q

Give the key decision variables for RT dose/approach for:

1) Rhabdo
2) Wilms
3) Ewings

A

Rhabdo (Surg->VAC-RT or not if SIOP):
Site (H&N/GU = 50.8Gy), Histo (RO alveolar 36/20), N+ (41/.4), Resection (alveolar or Embryonal R1 both get 36/20, R1 = gross = 50.4).

Wilms (NWTS is upfront surg +/-RT +/-Chemo):
Stg 3 = adjRT = surgical events - Bx (seeding), seeding, piecemeal resection, STR, Rupture.
Fav Histo and Stg 3 = 10.8/6Gy
Anaplasia = Unfav Histo = 19.8Gy/11#, R1/R2 = Boost 10.8/6
WART (10.5/7) if Spill, Peritoneal Seed, Ascites Cyto+, Rupture (SPAR).
Whole Lung if Mets: 12/8 (do SIOP approach, if Cr no RT to lung)

Ewings (VCDA-IE):
Response to chemo (<90 or >90%)
Surgical Events: R1/R2Spill rupture, Margin <1cm
Unresctable - neoAdj 45/25
Poor (<90%) response to chemo = prechemo GTV to 54/30
Good = 45/25 to prechemo, boost postchemo to 54/30.

58
Q

What is Xerostomia:

Broad causes in oncology setting:

CTCAE grades?

A

A sensation of dry mouth

May be due to:
1) Decreased salivary production

&/Or

2) Change in salivary constituents.
(i.e. does not need to be less saliva)

Causes:
RT- Radiation ductal endothelia injury
Medications: Oxybutynin especially, hyocine bromide
Salivary Graft versus Host disease

Grades:
1 = present
2 = Moderate Sx altering behaviour
3 = TPN/PEG indicated.

59
Q

Mx approach to Xerostomia

A

Prevention - quit smoking/EtOH, spare salivary glands on plan where possible.

Cytoprotection - Low quality evidence for amiphostine (but has side effects including nausea)

Harm minimise: Oral hygeine and dental review.

Sx Mx:
Cochran review doses not show significant long-term benefit to any intervention (i.e. beyond short term Sx relief)

  • Simple Bicarb and sodium MW
  • Oral gels and sprays
  • Losengers

Some limited evidence that acupuncture can improve salivation after RT.

60
Q

Define Osteoradionecrosis:

Incidence and RFs

When does it occur?

A

Exposed bone that does not heal (over 3 months), characterized by chronic necrosis &/or infection. Can lead to fistulas, fractures.

Around 5% in the modern era.

Pt RF: smoking, poor dental hygeine, advanced age, co-morbidities (T2DM)
Tumour: Invasion/Tstage, proximity to bone.
Treatment: Dose/fractionation/hotspots, concurrent chemo, aggressive surgery.

Onset typically 2-3years post.

61
Q

Sx/Signs of osteoradionecrosis

Ix and Dx

Grade/Stage systems:

A

Pain, ulceration/necrosis, trismus, halitosis, eating and speech difficulties, persistent infections, path #.

Ix/Dx:
Confirm is in RT field
Hx of preceding trauma/dental procedure (very common)
Radiologic - CT w/bone windows and MRI for soft tissue is useful
Consider and exclude cancer with Bx.

Grd 1 - asymptomatic finding
3 - Limiting ADLS - operative intervention
4 - Life-threatening
5- Death

Notani Stage -
I - Confined to alveolar bone.
II - Limited to alveolar bone AND mandible above alveolar canal.
III - Extends below alveolar canal to mandible AND either fistula &/or fracture

62
Q

Treatment of osteoradionecrosis:

Key variable?

A

(Dont forget prevention: including Jaw physio, hyperbaric O2 following dental procedure (limited evidence), Mx xerostomia, smoking cessation, chronmic illness optimisation, radiation technique).

Treatment depends on Notani stage I, II, III
“Requires multidisciplinary involvement”
Early stage Mx:
Analgesia
Antibiotics
Good oral Hygeine and smoking cessation
Debridement of devitalised tissue (and Bx)
Hyperbaric O2 (20 to 30#s)

Anti-radiation fibrosis drugs - PENTOCLO BD 5days a week.

Surgery:
Failure of conservative Mx, or Grd III (fistula/fractura)
Surgery and Hyperbaric O2 (20 to 30#s)

63
Q

Cancers that are most likely to cause bone mets?
What are the most common lytic bone metastases?

A

“PB KTL” = Lead (Pb Kettle)
Prostate, Breast, Kidney (RCC), Thyroid, Lung

Solid/scerotic = Prostate
Mixed = Breast.
Lytic = KTL
Also lytic = Melanoma and myeloma.